




Healthcare News Roundup: Neuro
HSMN NewsFeed - 9 Aug 2022
CereVasc Announces FDA Approval of Second IDE Study of the eShunt(R) System
CereVasc Announces FDA Approval of Second IDE Study of the eShunt(R) System
HSMN NewsFeed - 27 Jul 2022
Eisai Announces Key Executive Appointment for Alzheimer's Disease Leadership
Eisai Announces Key Executive Appointment for Alzheimer's Disease Leadership
HSMN NewsFeed - 6 Jul 2022
ClearMind Biomedical Clears FIM Clinical Trial for Least Invasive ICH Treatment to Date
ClearMind Biomedical Clears FIM Clinical Trial for Least Invasive ICH Treatment to Date